Explore emerging insights shaping the future of cancer care, from psychosocial outcomes and national data to advances in genomics and rare cancers. This session includes a rapid pitch presentation from Gilead Sciences, alongside research driving innovation in metastatic disease, Cancer of Unknown Primary, and evolving models of personalised care.

Time	Abstract Title	Presenter
16:00 – 16:25	When the SMS text Comes Through: Nursing the Patient on Sacituzumab Govitecan (Trodelvy®) in mTNBC (presentation sponsored by Gilead - click here for the full presentation synopsis)	Samantha Moules
16:30 – 16:45	TBC	TBC
16:45 – 17:00	Counted at last: Australia’s first national metastatic breast cancer prevalence estimate	Vicki Durston
17:00 – 17:15	Driving national change through interdisciplinary collaboration: SUPER-ED trial transforming care for cancer of unknown primary (CUP)	Sarah McLean
17:15 – 17:30	Impact and sustainability of extended genetic testing panels in a high-risk breast and ovarian cancer clinic	Trish Calder

Concurrent 9 | Emerging Insights

Session sponsor